LAIR-1 Agonism as a Therapy for Acute Myeloid Leukemia

The authors developed a therapeutic LAIR-1 agonist antibody, NC525, that induced cell death of leukemic stem cells (LSCs), but not healthy hematopoietic stem cells in vitro, and killed LSCs and AML blasts in both cell- and patient-derived xenograft models.